MITOCHONDRIAL DISEASES

Slides:



Advertisements
Similar presentations
Sporadic AD familial AD etiology environmental factors, genetic predisposition etiology oligomerization of A 42 and initial (diffuse) A 42 deposits subtle.
Advertisements

- D A N I S H A G I N G R E S E A R C H C E N T E R - Why do we age so differently? Tinna Stevnsner for Christina Poulsen Hvitby (on maternity.
Tianhong Pan, MD, PhD; Wenjie Xie, MD; Pawan Rawal,MD
Regulation of mitochondrial metabolism under respiratory and fermentative conditions in yeast Michel Rigoulet.
Glycolysis ط     Steps and key enzymes for glycolysis (irreversible reactions) ط     Dual role of glycolysis; degrades glucose to generate ATP and source.
Parkinson’s disease: February 19th BIOS E108 Parkin and PINK1
CELL BIOLOGY Mitochondria The organelle that releases energy in the cell. (The powerhouse of the cell) Only found in ANIMAL cells. Mitochondria.
Gerald Shadel, Departments of Pathology and Genetics
Mitochondria Guest lecturer: Chris Moyes, Dept of Biology Contact:
P691 Only those with specific transporters can pass All pathways related to fuel oxidation except glycolysis N side.
..
The genetics of mitochondrial disease
Effect of oxygen on the Escherichia coli ArcA and FNR regulation systems and metabolic responses Chao Wang Jan 23, 2006.
The Effects of Increased Net Reactive Oxygen Species on Mitophagy DONALD TA.
Cell Injury and Cell Death
Oxidative phosphorylation NADH transport Oxidative phosphorylation.
© 2007 McGraw-Hill Higher Education. All rights reserved. Chapter 3 Bioenergetics EXERCISE PHYSIOLOGY Theory and Application to Fitness and Performance,
W.X.B.6/28/20151 Production of Metabolic Energy Mitochondrial DiseasesMitochondrial Diseases Oxidation Reduction ReactionsOxidation Reduction Reactions.
Parkinson’s Disease Pathology 430/826 The Molecular Basis of Disease Neurological Genetics 9 th March 2015 Dr. John Rossiter
HEXA and Tay-Sachs Disease
Biologic Oxidation A.Energy is required to maintain the structure and function of the living cells. This energy is derived from oxidation of carbohydrates,lipids.
CELLULAR RESPIRATION BIOLOGY IB/ SL Option C.3.
WINDSOR SOM MITOCHONDRIA CELL BIOLOGY Dr. PURNA.
APOPTOSIS Pathway of cell death in which cells activate enzymes that degrade the cells’ own nuclear DNA and nuclear and cytoplasmic proteins.
Diseases that Result from Abnormal Mitochondrial Function Lu Qiping April 15, 2011.
Nutrient Role in Bioenergetics Chapter 4 Part 2. Bioenergetics-Glycolysis  Carbohydrates primary function  Energy for cellular work.  Breakdown of.
AEROBIC METABOLISM II: ELECTRON TRANSPORT CHAIN Khadijah Hanim Abdul Rahman School of Bioprocess Eng, UniMAP Week 15: 17/12/2012.
The Krebs Cycle Biology 11 Advanced
Redox buffering, respiration, and fermentation
MITOCHONDRIA (Powerhouse of the Cell). Mitochondria (singular, mitochondrion) – are typically tubular or rod-shaped organelles found in the cytoplasm.
Molecular Biology and Genetics of Amyotrophic Lateral Sclerosis Michael Sidel February 13, 2008.
Cell Respiration 3.7 and 8.1
Lecture 19: Cellular Respiration. By the end of this lecture you should be able to… Describe respiration as a redox reaction. Concepts and terms: reductant,
Aging and Reactive oxygen Species. Aging: What is it?  Aging, has been termed generally as a progressive decline in the ability of a physiological process.
A mitochondrial quality control pathway revealed from studies of familial Parkinson’s Disease genes Leo Pallanck Department of Genome Sciences.
Universal aspects of aging A&S Jim Lund “Age is not a particularly interesting subject. Anyone can get old. All you have to do is live long enough.”
Lecture (2)Physical Therapy for Geriatrics
Coordination of Intermediary Metabolism. ATP Homeostasis Energy Consumption (adult woman/day) – kJ (>200 mol ATP) –Vigorous exercise: 100x rate.
Cell death in PD: the case for mitochondria. Background defects in the capacity of the ubiquitin-proteasome system (UPS) to degrade unwanted proteins.
Cell Respiration 3.7 and 8.1
Mitochondrial function in Cell death in PD. Pathology Loss of SN pigmented dopamine neurons Lewy bodies Lewy neurites-multiple brain regions Lewy bodies.
Under the supervision of miklós jászberényi
Α-synuclein transgenic mouse models of Parkinson’s disease Michelle Maurer December 2015.
Biological Oxidation A.Energy is required to maintain the structure and function of the living cells. This energy is derived from oxidation of carbohydrates,lipids.
Mitochondria,Role &Function GR.Zamani, Pediatric Neurologist Children’s Medical Center,Tums,Dec.2013.
NS 315 Unit 4: Carbohydrate Metabolism
Sapana Shinde, Aaron Ripley, Dr. Sok Kean Khoo MicroRNA expression studies in rotenone- induced cellular model for Parkinson’s disease Department of Cell.
WINDSOR SOM CELL BIOLOGY
Overview of mechanisms underlying the main mitochondrial peripheral neuropathies. (A) MFN2 is located in the outer mitochondrial membrane and interacts.
Ying Cheng (1st-year PhD), supervised by Dr Gayle Doherty
Muscle Metabolism Dr. Nabil Bashir.
Normal And Abnormal Cardiac Muscle Metabolism
III. Parkinson Disease.
Alpha-synuclein in Parkinson's disease
The Krebs Cycle Biology 11 Advanced
Abstract Mitophagy is essential for cellular homeostasis, but how mitophagy is regulated is largely unknown. Here we found that the kinase Jnk2.
Alicia M. Pickrell, Richard J. Youle  Neuron 
ALS disease pathology and proposed disease mechanisms.
Cellular Respiration Biology 11
PINK1 and Parkin Flag Miro to Direct Mitochondrial Traffic
2/15/2019 Shadab Salehpour.
Parkinson's Disease Neuron
Autophagy in the Pathogenesis of Disease
Mitochondria: In Sickness and in Health
MITOCHONDRIA F.Y.B.Sc 12/10/2017 By Dr.Pandharbale Ashok
The Ubiquitin Proteasome System in Neurodegenerative Diseases
The Mitochondrial Rhomboid Protease PARL Is Regulated by PDK2 to Integrate Mitochondrial Quality Control and Metabolism  Guang Shi, G. Angus McQuibban 
Chapter 18 Dietary Phytochemicals in Neurodegenerative Disease
PD-associated gene products and their prospective sites of cellular function PD is hypothesized to be a consequence of the dysfunction of intersecting.
A Proposed Mechanism for Neurodegeneration in Movement Disorders Characterized by Metal Dyshomeostasis and Oxidative Stress  Benjamin Guy Trist, Dominic.
Presentation transcript:

MITOCHONDRIAL DISEASES PHM142 UNIT 7 MITOCHONDRIAL DISEASES PART 1 - Introduction

The mitochondrial energy-generating system

Mitochondrial Myopathies Genetic defects in mitochondrial structure & function leading to defective aerobic energy transduction and resulting in: exercise intolerance, lactic acidosis, stroke/seizure, headaches.

Assays for mitochondrial dysfunction

Nijmegen Center for Mitochondrial Disorders The table gives the percentage of fresh muscle samples that showed an activity below the lowest control value. Results from frozen muscle samples are not included in this table. In total, 1,406 fresh muscle samples were examined. Of these, 39% showed a reduced rate of ATP production from the oxidation of pyruvate and malate. Approximately 2/3 of the samples with a reduced ATP production rate also showed a reduced activity of one or more OXPHOS enzymes.

Mitochondrial dysfunction in neurodevelopmental disorders PHM142 UNIT 8A Mitochondrial dysfunction in neurodevelopmental disorders (e.g. autism)

Of the 120 children with ASD studied by Oliveira, 2005 detailed metabolic studies including plasma lactate were performed in 69. Elevated lactate was found in 14, of whom 11 underwent muscle biopsy. Five of these children were diagnosed with definite mitochondrial disease. Thus, 4.2% of 120 children with ASD were determined to have definite mito disease. <> This is likely an underestimate.

Abnormalities in Mitochondria Function in Autism C. Giulivi et al., 2010 JAMA 304: 2389

JAMA. 2010;304(21):2389-2396 Conclusions: In this exploratory study, children with autism were more likely to have mitochondrial dysfunction, mtDNA over-replication, and mtDNA deletions than typically developing children. Using the control values to define a reference range (set at 99% CI) for the individual data, low NADH oxidase activity was the most common deficiency (8 of 10), followed by succinate oxidase (6/10). The lactate-to-pyruvate ratio reflects the redox state of the cytosolic compartment, such that a lactate-to-pyruvate ratio of 12 (as in controls) indicates a ratio of oxidized NADH to reduced NADH of 750:1, and a lactate-to-pyruvate ratio of 6 (as in autism) indicates a ratio of oxidized NADH to reduced NADH of 1500:1. A more oxidized cytosolic redox state in autism could favor anaerobic glycolysis over oxidative phosphorylation as a source of adenosine triphosphate. Although skeletal muscle can tolerate this shift in metabolism, consequences for brain function could be devastating due to its heavy reliance on mitochondrial oxidative phosphorylation to generate the energy needed for cellular processes. The rates of H2O2 production in lymphocytic mitochondria from children with autism were higher compared with controls at both complex I and complex III. Thus, lymphocytic mitochondria in autism not only had a lower oxidative phosphorylation, but also an increase in cellular oxidative stress.

PHM 142 UNIT 8B Mitochondrial function in neurodegenerative disorders

- The loss of autophagy-related genes results in neurodegeneration and abnormal protein accumulation. Autophagy is a bulk lysosomal degradation pathway essential for the turnover of long-lived, misfolded or aggregated proteins, as well as damaged or excess organelles. The accumulation and aggregation of a-synuclein is a characteristic feature of PD. Over-expression of a-synuclein is thought to impair autophagy, suggesting the presence of a cycle of impairment and accumulation. Prior studies have shown that a-synuclein is degraded by chaperone-mediated autophagy. - Neurotoxins affecting humans and also used in animal models of PD: MPTP, 6-hydroxy-dopamine (6-OHDA), rotenone, and paraquat   MPTP, a selective inhibitor of PD mitochondrial complex I, directed researchers’ attention to pathological roles of mitochondria in PD and raised the possibility that environmental toxins affecting mitochondria might cause PD. Other mitochondrial toxins characterized as parkinsonism-inducing reagents include 6-OHDA, rotenone, and paraquat. Studies of animal models of PD induced with these toxins suggest that mitochondrial dysfunction and oxidative stress are important pathogenic mechanisms. In humans, reduced complex I activity has been reported in both post-mortem brain samples and platelets of sporadic/idiopathic PD cases. - Lewy bodies observed in PD brain tissue are proteinaceous intracellular inclusions containing ubiquitin and a-synuclein among many other components. The protein Parkin, mutated in the most common cause of recessive PD, may mediate the clearance of abnormal mitochondria through autophagy. Recent studies have revealed that genes associated with autosomal recessive forms of PD such as PINK1 and Parkin are directly involved in regulating mitochondrial morphology and maintenance, abnormality of which is also observed in the more common, idiopathic forms of PD. Note however that the autosomal recessive PDs lack Lewy-body pathology that is characteristic of idiopathic PD.

From Fig. above Mitochondrial fusion and fission events are required for the maintenance of a healthy mitochondrial population (beige). Mitochondrial fusion is thought to facilitate the interchange of internal components such as copies of the mitochondrial genome, respiratory proteins and metabolic products. Mitochondrial fission may play a role in the removal of dysfunctional mitochondria (dark red) with reduced mitochondrial membrane potential (Dcm), through an autophagy-lysosomal pathway named ‘mitophagy’. PINK1 and Parkin are likely to be involved in this process. PINK1 normally has a short half-life in healthy mitochondria. Upon reduction of the Dcm, PINK1 is stabilized on the outer membrane; then accumulation of PINK1 induces the translocation of Parkin from the cytosol to the mitochondria, leading to Parkin-dependent ubiquitination and degradation of the mitochondrial proteins, and subsequent activation of the autophagy machinery. Ubiquitinated proteins of the mitochondria are shown as ovals with small orange circles. Recent studies of Parkin-deficient or PINK1-deficient mice have reported morpho-logical and functional alterations of mitochondria in both neurons and astrocytes . Also, a missense mutation in another gene called PARL found in PD cases abolishes its PINK1-processing activity and the ensuing Parkin-mediated mitophagy.

Regulation of mitophagy by PINK1 and Parkin (genes linked to PD) Current Opinion in Neurobiology 2011, 21:935–941

Summary a new hypothesis on mitochondrial involvement in PD Prominent pathological features of PD include mitochondrial dysfunction and the accumulation of protein inclusions into Lewy-bodies in dopaminergic neurons. These disease phenotypes could arise from impairments in the cellular quality control systems for mitochondria and cytoplasmic proteins involving mitochondrial fission/fusion dynamics, the ubiquitin–proteasome system, and the autophagy pathway.